Skip to main content
Download PDF

Correction to: EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex

Journal of Biomedical Science volume 27, Article number: 100 (2020) Cite this article

The Original Article was published on 09 January 2015

Correction to: J Biomed Sci (2015) 22:4 https://doi.org/10.1186/s12929-014-0108-9

After published the article [1] the author became aware of a mistake in the Fig. 4 (upper panel section C). Due to an error that occurred inadvertently at the time of figure assembly, an incorrect image for ScrApt alone sample was included.

The correct version of the Fig. 4 is given below. This change does not affect the conclusions and interpretations of the article in any way. The authors sincerely apologize for this unintentional error.

Fig. 4
figure 1

Cell Uptake of the PEI nanocomplex by MCF-7 and WERI-Rb1 cells. The fabricated PEI complexes and free aptamer were added to MCF-7 cells (upper panel a–e), WERI-Rb1 cells (lower panel a–e) and incubated for their uptake at 37 °C for 4 h followed by DAPI counterstaining and microscopic evaluation. Images were taken at 40 × using AxioObserver fluorescent microscope. Legend on the top of phase image represents the aptamer or nanocomplex added to the respective panel

Full size image

Reference

  1. Subramanian, et al. EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex. J Biomed Sci. 2015;22:4. https://doi.org/10.1186/s12929-014-0108-9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Open Access

This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Author information

Authors and Affiliations

  1. Department of Nanobiotechnology, Vision Research Foundation, Kamalnayan Bajaj Institute for Research in Vision and Ophthalmology, Tamil Nadu, 18 College Road, Chennai, 600006, India

    Nithya Subramanian, Prasanna kumar Athalya, Narayanan Janakiraman, Sailaja Eluchuri & Subramanian Krishnakumar

  2. Nanomedicine Laboratory of Immunology and Molecular Biomedical Research (LIMBR), School of Medicine (SoM), Molecular and Medical Research (MMR) Strategic Research Centre, Faculty of Health, Deakin University, Geelong, VIC, 3217, Australia

    Nithya Subramanian, Jagat R. Kanwar, Prasanna kumar Athalya & Rupinder K. Kanwar

  3. L & T Ocular Pathology Department, Vision Research Foundation, Kamalnayan Bajaj Institute for Research in Vision and Ophthalmology, Chennai, India

    Subramanian Krishnakumar

  4. Departments of Ocular Oncology and Vitreoretina, Medical Research Foundation, Sankara Nethralaya, Chennai, India

    Vikas Khetan

Authors
  1. Nithya Subramanian
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jagat R. Kanwar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Prasanna kumar Athalya
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Narayanan Janakiraman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Vikas Khetan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Rupinder K. Kanwar
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Sailaja Eluchuri
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Subramanian Krishnakumar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Jagat R. Kanwar or Subramanian Krishnakumar.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Subramanian, N., Kanwar, J.R., Athalya, P. et al. Correction to: EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex. J Biomed Sci 27, 100 (2020). https://doi.org/10.1186/s12929-020-00687-2

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12929-020-00687-2

Journal of Biomedical Science

ISSN: 1423-0127